Tag: Vaccines
Two Doses of Recombinant Zoster Vaccine Highly Effective
Vaccine effectiveness wanes after one dose but remains relatively unchanged over four years after two doses
BNT162b2 Effective for Children, Teens During Delta, Omicron Waves
Estimated effectiveness did not wane during delta period but did decline against the omicron variant after the first dose
Many U.S. Nursing Home Residents Have Not Been Vaccinated for Flu, COVID-19, or RSV...
Second study shows that 42.2 and 18.3 percent of individuals aged 18 years and older reported receiving flu, updated COVID-19 shots
Single Dose of mRNA-1345 Vaccine Safe, Effective Against RSV in Seniors
Vaccine efficacy was 68.4 percent against RSV-associated acute respiratory disease; offers protection against subtypes A and B
Recombinant Vaccine Confers More Protection Against Influenza
High-dose recombinant vaccine more effective than egg-based standard-dose vaccine among adults aged 50 to 64
Effectiveness of Live Zoster Vaccine Wanes Over Time
Vaccine effectiveness highest in first year after vaccination and decreases considerably over time
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
Fourth dose reduces risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs
COVID-19 Vaccination Before Infection Cuts Risk for Long COVID
COVID-19 vaccination with any number of doses before infection linked to reduced risk for post-COVID-19 condition
Measles Vaccination Coverage Still Below Prepandemic Levels
Coverage with first dose of measles-containing vaccine decreased to 81 percent in 2021 during pandemic
Measles Vaccination Has Averted 57 Million Deaths Since 2000
Coverage with first dose of measles-containing vaccine decreased to 81 percent in 2021 during pandemic
